Impact of intravenous Iron on Musculoskeletal Function in Older Adults

  • Research type

    Research Study

  • Full title

    Impact of Intravenous Iron (Ferinject) on Musculoskeletal Function Profiles in Older Adults with Iron Deficiency Anaemia (IDA)

  • IRAS ID

    253852

  • Contact name

    Omid Khaiyat

  • Contact email

    alizado@hope.ac.uk

  • Sponsor organisation

    Liverpool Hope University

  • Eudract number

    2020-000056-35

  • ISRCTN Number

    ISRCTN00000000

  • Clinicaltrials.gov Identifier

    NCT00000000

  • Clinicaltrials.gov Identifier

    Not Applicable, Not Applicable

  • Duration of Study in the UK

    3 years, 0 months, 0 days

  • Research summary

    Anaemia is a risk factor for functional decline and frailty in older adults including decreased physical performance and muscle strength, increased hospitalisation risk and mortality, falls, and poorer recovery from activities of daily living. Despite a major gap in human studies, research in animals has demonstrated an interrelationship between iron deficiency anaemia and deteriorated functional capacity and physical performance particularly in older adults. Iron deficiency and associated anaemia is a frequent accompanier of debilitating chronic diseases such as heart failure and chronic lung diseases. These conditions, more commonly seen in older patients, are strongly linked to deterioration in physical function, reduced skeletal muscle mass and quality, frailty, and poor quality of life. Exercise intolerance is also a common feature of these conditions as iron deficiency impairs the capacity of carrying oxygen leading to inability to sustain physical activities. Furthermore, the age-related decline in the muscle mass and quality (so called sarcopenia) and associated frailty has rapidly become a major health concern in the older adults particularly when accompanied by other chronic diseases. Recently, there has been an increasing interest in exploring the role of iron as a causative factor in the development of sarcopenia and related frailty.
    In summary, there is a substantial gap of evidence whether Iron repletion leads to meaningful enhancements in the skeletal muscle function and physical performance in older adults suffering from iron deficiency anaemia. This study will investigate the impact of a standard care intervention (intravenous iron therapy) on muscular function and physical performance in older patients through a range of laboratory assessments.

  • REC name

    North West - Liverpool Central Research Ethics Committee

  • REC reference

    20/NW/0090

  • Date of REC Opinion

    16 Sep 2020

  • REC opinion

    Further Information Favourable Opinion